Replacement of Collateral Agent. Upon written notice by 50% of the Purchasers that such Purchasers object to Cavalry Fund I LP serving as Collateral Agent under this Agreement, Cavalry Fund I LP shall be replaced as Collateral Agent by a person or entity which shall be acceptable to at least 50% of the Purchasers.
Appears in 4 contracts
Samples: Security Agreement, Security Agreement (OncBioMune Pharmaceuticals, Inc), Security Agreement (OncBioMune Pharmaceuticals, Inc)
